Literature DB >> 26494611

Translational challenges for the development of a novel nucleus pulposus substitute: Experimental results from biomechanical and in vivo studies.

S E L Detiger1, J Y de Bakker1, K S Emanuel1, M Schmitz1, P P A Vergroesen1, A J van der Veen2, C Mazel3, T H Smit4.   

Abstract

Nucleus pulposus replacement therapy could offer a less invasive alternative to restore the function of moderately degenerated intervertebral discs than current potentially destructive surgical procedures. Numerous nucleus pulposus substitutes have already been investigated, to assess their applicability for intradiscal use. Still, the current choice of testing methods often does not lead to efficient translation into clinical application. In this paper, we present the evaluation of a novel nucleus pulposus substitute, consisting of a hydromed core and an electrospun envelope. We performed three mechanical evaluations and an in vivo pilot experiment. Initially, the swelling pressure of the implant was assessed in confined compression. Next, we incorporated the implant into mechanically damaged caprine lumbar intervertebral discs to determine biomechanical segment behaviour in bending and torsion. Subsequently, segments were serially tested in native, damaged and repaired conditions under dynamic axial compressive loading regimes in a loaded disc culture system. Finally, nucleus pulposus substitutes were implanted in a live goat spine using a transpedicular approach. In confined compression, nucleus pulposus samples as well as implants showed some load-bearing capacity, but the implant exhibited a much lower absolute pressure. In bending and torsion, we found that the nucleus pulposus substitute could partly restore the mechanical response of the disc. During dynamic axial compression in the loaded disc culture system, on the other hand, the implant was not able to recover axial compressive behaviour towards the healthy situation. Moreover, the nucleus pulposus substitutes did not remain in place in the in vivo situation but migrated out of the disc area. From these results, we conclude that implants may mimic native disc behaviour in simple mechanical tests, yet fail in other, more realistic set-ups. Therefore, we recommend that biomaterials for nucleus pulposus replacement be tested in testing modalities of increasing complexity and in their relevant anatomical surroundings, for a more reliable prediction of clinical potential.
© The Author(s) 2015.

Entities:  

Keywords:  Nucleus pulposus; confined compression; intervertebral disc degeneration; mechanical behaviour; regenerative medicine

Mesh:

Substances:

Year:  2015        PMID: 26494611     DOI: 10.1177/0885328215611946

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN: 0885-3282            Impact factor:   2.646


  4 in total

1.  Translation of an injectable triple-interpenetrating-network hydrogel for intervertebral disc regeneration in a goat model.

Authors:  Sarah E Gullbrand; Thomas P Schaer; Prateek Agarwal; Justin R Bendigo; George R Dodge; Weiliam Chen; Dawn M Elliott; Robert L Mauck; Neil R Malhotra; Lachlan J Smith
Journal:  Acta Biomater       Date:  2017-07-19       Impact factor: 8.947

2.  Linear and Nonlinear Biphasic Mechanical Properties of Goat IVDs Under Different Swelling Conditions in Confined Compression.

Authors:  Akbar Rasoulian; Farid Vakili-Tahami; Theodoor H Smit
Journal:  Ann Biomed Eng       Date:  2021-09-03       Impact factor: 3.934

3.  Examination of an in vitro methodology to evaluate the biomechanical performance of nucleus augmentation in axial compression.

Authors:  Sebastien Nf Sikora; Danielle E Miles; Sami Tarsuslugil; Marlène Mengoni; Ruth K Wilcox
Journal:  Proc Inst Mech Eng H       Date:  2018-01-13       Impact factor: 1.617

4.  The influence of artificial nucleus pulposus replacement on stress distribution in the cartilaginous endplate in a 3-dimensional finite element model of the lumbar intervertebral disc.

Authors:  Yu Wang; Xiao-Dong Yi; Chun-De Li
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.